BELL logo

Belluscura plc Stock Price

AIM:BELL Community·UK£3.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

BELL Share Price Performance

UK£0.0075
-0.10 (-92.86%)
UK£0.0075
-0.10 (-92.86%)
Price UK£0.0075

BELL Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
1 Reward

Belluscura plc Key Details

US$1.8m

Revenue

US$5.4m

Cost of Revenue

-US$3.6m

Gross Profit

US$15.0m

Other Expenses

-US$18.6m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-0.046
-197.53%
-1,030.73%
0%
View Full Analysis

About BELL

Founded
2015
Employees
35
CEO
Robert Rauker
WebsiteView website
www.belluscura.com

Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

Recent BELL News & Updates

Recent updates

No updates